Signaling pathways
-
BA5431 LML134Summary: LML134 (compound 18b) is an orally active, highly selective (histamine 3 receptor) inverse agonist. - BA5432 JZP-361Summary: JZP-361 is a potent, reversible and selective inhibitor of human recombinant (hMAGL).
- BA5433 PF-03654764Summary: PF-03654764 is an orally active, selective histamine receptor antagonist.
- BA5434 ChlorphenoxamineSummary: An antihistamine and anticholinergic used as an antiparkinsonian agent.
- BA5435 ST-1006Summary: ST-1006 is a potent histamine H4 receptor agonist.
- BA5436 MK-0249Summary: MK-0249 is a potent, selective, orally active receptor antagonist.
- BA5437 BavisantSummary: Bavisant (JNJ-31001074) is an orally effective, blood-brain barrier-crossing, and highly selective histamine receptor antagonist.
- BA5439 TecastemizoleSummary: Tecastemizole (Norastemizole), the major metabolite of Astemizole, is a potent and selective antagonist.
- BA5440 Thonzylamine (Standard)
- BA5441 N-AcetyldesloratadineSummary: N-Acetyldesloratadine (SCH-37370) is a potent, orally active dual antagonist of platelet-activating factor and histamine.